Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Acta Neuropathologica(2022)10.1007/s00401-022-02433-4Source: DataRank Database

Alzheimer disease neuropathology in a patient previously treated with aducanumab is a research paper published in Acta Neuropathologica (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.95)OA: hybridTopics (42)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Thierry Bussière ORCID,Raj Rajagovindan,Jennifer Sebalusky ORCID,Stefan Hamann ORCID,Christian von Hehn

Live enrichment

PubMed:35581440 OpenAlex:https://openalex.org/W4280495704

National Institute on Aging

Grant: P30-AG066508

National Institute on Aging

Grant: P50-AG047270-01

National Institutes of Health

Grant: 5P50AG047270-03

Yale Alzheimer Disease Research Center

National Institutes of Health

Grant: 5P30AG066508-03

Yale Alzheimer Disease Research Center

FWCI

4.95

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00401-022-02433-4.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00401-022-02433-4.pdf

publisherhttps://link.springer.com/article/10.1007/s00401-022-02433-4/fulltext.html

journalhttps://doi.org/10.1007/s00401-022-02433-4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35581440

Fields of Study

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAluminum toxicity and tolerance in plants and animals03 medical and health sciences0302 clinical medicine

MeSH Terms

Aged, 80 and overAlzheimer DiseaseAmyloidFemaleHumansRandomized Controlled Trials as TopicAmyloid beta-PeptidesNeurofibrillary TanglesClinical Trials, Phase I as TopicPositron-Emission TomographyPlaque, AmyloidAntibodies, Monoclonal, Humanized

Keywords

NeuropathologyPathologyMedicineAmyloid (mycology)Senile plaquesAlzheimer's diseasePositron emission tomographyDementiaAutopsyImmunohistochemistryNuclear medicineDiseaseAged, 80 and overAmyloidAmyloid beta-PeptidesClinical Trials, Phase I as TopicCase ReportNeurofibrillary TanglesPlaque, AmyloidAntibodies, Monoclonal, HumanizedAlzheimer DiseasePositron-Emission TomographyHumansFemaleRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being